Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Short term Debt: 2010-2024

Historic Short term Debt for OptimizeRx (OPRX) over the last 5 years, with FY2024 value amounting to $2.0 million.

  • OptimizeRx's Short term Debt rose 6500.0% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 6500.0%. This contributed to the annual value of $2.0 million for FY2024, which is 0.0% changed from last year.
  • As of FY2024, OptimizeRx's Short term Debt stood at $2.0 million, which was down 0.0% from $2.0 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Short term Debt ranged from a high of $2.0 million in FY2023 and a low of $285795.0 during FY2020
  • Over the past 3 years, OptimizeRx's median Short term Debt value was $2.0 million (recorded in 2023), while the average stood at $1.4 million.
  • In the last 5 years, OptimizeRx's Short term Debt plummeted by 5072.62% in 2020 and then changed by 0.0% in 2024.
  • Annual analysis of 3 years shows OptimizeRx's Short term Debt stood at $285795.0 in 2020, then surged by 599.8% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024.
  • Its Short term Debt was $2.0 million in FY2024, compared to $2.0 million in FY2023 and $285795.0 in FY2020.